2023 Q4 Form 10-Q Financial Statement
#000095017023061080 Filed on November 08, 2023
Income Statement
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
Revenue | $1.676M | $1.944M |
YoY Change | -96.22% | -87.02% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $17.94M | $18.95M |
YoY Change | -16.91% | -12.09% |
% of Gross Profit | ||
Research & Development | $31.82M | $34.28M |
YoY Change | -63.51% | -57.06% |
% of Gross Profit | ||
Depreciation & Amortization | $4.885M | $4.740M |
YoY Change | 0.89% | 48.45% |
% of Gross Profit | ||
Operating Expenses | $49.75M | $53.22M |
YoY Change | -54.26% | -47.5% |
Operating Profit | -$51.28M | |
YoY Change | -40.64% | |
Interest Expense | $3.769M | $5.750M |
YoY Change | -53.21% | 114.71% |
% of Operating Profit | ||
Other Income/Expense, Net | $184.0K | $6.109M |
YoY Change | 116.02% | |
Pretax Income | -$44.12M | -$45.17M |
YoY Change | -21.72% | -45.94% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$44.12M | -$45.17M |
YoY Change | -21.72% | -45.94% |
Net Earnings / Revenue | -2632.58% | -2323.56% |
Basic Earnings Per Share | -$0.46 | |
Diluted Earnings Per Share | -$0.45 | -$0.46 |
COMMON SHARES | ||
Basic Shares Outstanding | 98.60M | 98.56M |
Diluted Shares Outstanding | 98.57M |
Balance Sheet
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $315.2M | $349.7M |
YoY Change | -27.75% | -30.77% |
Cash & Equivalents | $41.87M | $33.33M |
Short-Term Investments | $273.3M | $316.4M |
Other Short-Term Assets | $14.54M | $12.90M |
YoY Change | -46.87% | -35.4% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $1.826M | $1.538M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $331.5M | $364.2M |
YoY Change | -33.97% | -31.97% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $96.84M | $101.7M |
YoY Change | -11.98% | -6.79% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $980.0K | $0.00 |
YoY Change | -80.17% | -100.0% |
Other Assets | $9.000K | $9.000K |
YoY Change | -72.73% | -72.73% |
Total Long-Term Assets | $174.7M | $179.6M |
YoY Change | -14.16% | -16.08% |
TOTAL ASSETS | ||
Total Short-Term Assets | $331.5M | $364.2M |
Total Long-Term Assets | $174.7M | $179.6M |
Total Assets | $506.2M | $543.8M |
YoY Change | -28.25% | -27.43% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $4.719M | $5.706M |
YoY Change | -42.9% | -40.52% |
Accrued Expenses | $27.51M | $28.54M |
YoY Change | -48.98% | -43.09% |
Deferred Revenue | $685.0K | $1.110M |
YoY Change | -98.38% | -96.85% |
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $39.09M | $41.33M |
YoY Change | -65.72% | -60.23% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $98.71M | $99.70M |
YoY Change | -8.24% | -21.75% |
Total Long-Term Liabilities | $98.71M | $99.70M |
YoY Change | -8.24% | -21.75% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $39.09M | $41.33M |
Total Long-Term Liabilities | $98.71M | $99.70M |
Total Liabilities | $137.8M | $141.0M |
YoY Change | -37.82% | -39.05% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$1.212B | -$1.168B |
YoY Change | 15.31% | 17.41% |
Common Stock | $99.00K | $99.00K |
YoY Change | 2.06% | 2.06% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $368.4M | $402.8M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $506.2M | $543.8M |
YoY Change | -28.25% | -27.43% |
Cashflow Statement
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$44.12M | -$45.17M |
YoY Change | -21.72% | -45.94% |
Depreciation, Depletion And Amortization | $4.885M | $4.740M |
YoY Change | 0.89% | 48.45% |
Cash From Operating Activities | -$36.64M | -$38.28M |
YoY Change | -51.4% | -30.46% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $181.0K | $560.0K |
YoY Change | -97.29% | -106.45% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $45.53M | $25.37M |
YoY Change | -23.84% | -71.51% |
Cash From Investing Activities | $45.35M | $24.80M |
YoY Change | -14.61% | -69.15% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -180.0K | 0.000 |
YoY Change | -111.87% | -100.0% |
NET CHANGE | ||
Cash From Operating Activities | -36.64M | -38.28M |
Cash From Investing Activities | 45.35M | 24.80M |
Cash From Financing Activities | -180.0K | 0.000 |
Net Change In Cash | 8.536M | -13.48M |
YoY Change | -141.12% | -150.26% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$36.64M | -$38.28M |
Capital Expenditures | $181.0K | $560.0K |
Free Cash Flow | -$36.82M | -$38.84M |
YoY Change | -55.14% | -16.24% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001434316 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
us-gaap |
Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
|
true | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2023Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023Q3 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
http://fasb.org/us-gaap/2023#LicenseMember | |
CY2022Q3 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
http://fasb.org/us-gaap/2023#LicenseMember | |
us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
http://fasb.org/us-gaap/2023#LicenseMember | ||
us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
http://fasb.org/us-gaap/2023#LicenseMember | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-36076 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
FATE THERAPEUTICS, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
65-1311552 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
12278 Scripps Summit Drive | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
San Diego | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92131 | ||
dei |
City Area Code
CityAreaCode
|
858 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
875-1800 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock | ||
dei |
Trading Symbol
TradingSymbol
|
FATE | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
98601966 | |
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
33334000 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
61333000 | |
CY2023Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1538000 | |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
38480000 | |
CY2023Q3 | fate |
Short Term Investments And Related Maturity Receivables
ShortTermInvestmentsAndRelatedMaturityReceivables
|
316400000 | |
CY2022Q4 | fate |
Short Term Investments And Related Maturity Receivables
ShortTermInvestmentsAndRelatedMaturityReceivables
|
374894000 | |
CY2023Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
12902000 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
27367000 | |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
364174000 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
502074000 | |
CY2023Q3 | us-gaap |
Long Term Investments
LongTermInvestments
|
0 | |
CY2022Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
4942000 | |
CY2023Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
101707000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
110020000 | |
CY2023Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
62721000 | |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
66069000 | |
CY2023Q3 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
15177000 | |
CY2022Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
15227000 | |
CY2023Q3 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
0 | |
CY2022Q4 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
7196000 | |
CY2023Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
9000 | |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
33000 | |
CY2023Q3 | us-gaap |
Assets
Assets
|
543788000 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
705561000 | |
CY2023Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5706000 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8265000 | |
CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
28540000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
53932000 | |
CY2023Q3 | fate |
Cirm Award Liability Current
CIRMAwardLiabilityCurrent
|
0 | |
CY2022Q4 | fate |
Cirm Award Liability Current
CIRMAwardLiabilityCurrent
|
4000000 | |
CY2023Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1110000 | |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
42226000 | |
CY2023Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
5977000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
5628000 | |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
41333000 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
114051000 | |
CY2023Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
98977000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
103710000 | |
CY2023Q3 | fate |
Stock Price Appreciation Milestones Liabilities Non Current
StockPriceAppreciationMilestonesLiabilitiesNonCurrent
|
701000 | |
CY2022Q4 | fate |
Stock Price Appreciation Milestones Liabilities Non Current
StockPriceAppreciationMilestonesLiabilitiesNonCurrent
|
3861000 | |
CY2023Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2023Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
3000 | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
3000 | |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
98585750 | |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
98585750 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
97294917 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
97294917 | |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
99000 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
97000 | |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1570784000 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1536497000 | |
CY2023Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-499000 | |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1854000 | |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1167610000 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1050804000 | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
402777000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
483939000 | |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
543788000 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
705561000 | |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1944000 | |
CY2022Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
14981000 | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
61857000 | ||
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
51944000 | ||
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
34275000 | |
CY2022Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
79817000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
140780000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
233263000 | ||
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
18948000 | |
CY2022Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
21555000 | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
63513000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
62648000 | ||
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
53223000 | |
CY2022Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
101372000 | |
us-gaap |
Operating Expenses
OperatingExpenses
|
204293000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
295911000 | ||
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-51279000 | |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-86391000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-142436000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-243967000 | ||
CY2023Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
4697000 | |
CY2022Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1787000 | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
12772000 | ||
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2962000 | ||
CY2023Q3 | fate |
Increase Decrease In Fair Value Of Stock Price Appreciation Milestones
IncreaseDecreaseInFairValueOfStockPriceAppreciationMilestones
|
-1049000 | |
CY2022Q3 | fate |
Increase Decrease In Fair Value Of Stock Price Appreciation Milestones
IncreaseDecreaseInFairValueOfStockPriceAppreciationMilestones
|
-891000 | |
fate |
Increase Decrease In Fair Value Of Stock Price Appreciation Milestones
IncreaseDecreaseInFairValueOfStockPriceAppreciationMilestones
|
-3160000 | ||
fate |
Increase Decrease In Fair Value Of Stock Price Appreciation Milestones
IncreaseDecreaseInFairValueOfStockPriceAppreciationMilestones
|
-15131000 | ||
CY2023Q3 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
363000 | |
CY2022Q3 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
150000 | |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
9698000 | ||
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
516000 | ||
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
6109000 | |
CY2022Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2828000 | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
25630000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
18609000 | ||
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-45170000 | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-83563000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-116806000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-225358000 | ||
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
88000 | |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
128000 | |
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
1355000 | ||
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-2491000 | ||
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-45082000 | |
CY2022Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-83435000 | |
us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-115451000 | ||
us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-227849000 | ||
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.46 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.46 | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.86 | |
CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.86 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.19 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.19 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.33 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.33 | ||
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
98568012 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
98568012 | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
97023506 | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
97023506 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
98342898 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
98342898 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
96692974 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
96692974 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-116806000 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-225358000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
13397000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8916000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
33984000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
59341000 | ||
us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
8492000 | ||
us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-989000 | ||
us-gaap |
Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
|
7196000 | ||
us-gaap |
Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
|
1546000 | ||
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-41116000 | ||
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-959000 | ||
fate |
Increase Decrease In Fair Value Of Stock Price Appreciation Milestones
IncreaseDecreaseInFairValueOfStockPriceAppreciationMilestones
|
-3160000 | ||
fate |
Increase Decrease In Fair Value Of Stock Price Appreciation Milestones
IncreaseDecreaseInFairValueOfStockPriceAppreciationMilestones
|
-15131000 | ||
fate |
Grant Income From Cirm Award
GrantIncomeFromCirmAward
|
4000000 | ||
fate |
Grant Income From Cirm Award
GrantIncomeFromCirmAward
|
0 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-36942000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1547000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-14512000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
10924000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-27047000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
10865000 | ||
fate |
Increase Decrease In Right Of Use Assets And Lease Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet
|
-1036000 | ||
fate |
Increase Decrease In Right Of Use Assets And Lease Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet
|
-557000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-95626000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-172819000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5972000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
28889000 | ||
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
308844000 | ||
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
297694000 | ||
us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
382128000 | ||
us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
440222000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
67312000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
113639000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
265000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
7690000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
265000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
7690000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-28049000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-51490000 | ||
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
76560000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
148810000 | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
48511000 | |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
97320000 | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
168000 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1988000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
62000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
682000 | ||
us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
|
0.60 | ||
CY2023Q3 | us-gaap |
Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
|
12900000 | |
us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
10900000 | ||
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
2000000 | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s unaudited condensed consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (U.S. GAAP). The preparation of the Company’s unaudited condensed consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s unaudited condensed consolidated financial statements and accompanying notes. The most significant estimates and assumptions in the Company’s unaudited condensed consolidated financial statements relate to its stock price appreciation milestone obligations, contracts containing leases, and accrued expenses. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</span></p> | ||
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
33334000 | |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
82093000 | |
CY2023Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
15177000 | |
CY2022Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
15227000 | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
48511000 | |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
97320000 | |
CY2023Q3 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
15200000 | |
CY2022Q3 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
15200000 | |
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
1910000 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27500000 | ||
CY2023Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27500000 | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27300000 | ||
CY2022Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27300000 | |
fate |
Proceeds From Research And Development Fees Received
ProceedsFromResearchAndDevelopmentFeesReceived
|
82000000 | ||
fate |
Expected Ressarch Services Period
ExpectedRessarchServicesPeriod
|
P4Y | ||
CY2023Q3 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
268108000 | |
CY2023Q3 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
499000 | |
CY2022Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
270967000 | |
CY2022Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
1899000 | |
us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
0 | ||
CY2023Q3 | us-gaap |
Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
|
0 | |
us-gaap |
Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
|
0 | ||
CY2022Q3 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
0 | |
CY2023Q3 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
0 | |
CY2022Q3 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
0 | |
CY2023Q3 | us-gaap |
Share Price
SharePrice
|
2.12 | |
CY2023Q3 | us-gaap |
Share Price
SharePrice
|
2.12 | |
CY2023Q3 | fate |
Fairvalueassetslevel1 Tolevel2 Transfersamounts
Fairvalueassetslevel1Tolevel2Transfersamounts
|
0 | |
CY2023Q3 | fate |
Fairvalueassetslevel2 Tolevel1 Transfersamounts
Fairvalueassetslevel2Tolevel1Transfersamounts
|
0 | |
CY2023Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
3923000 | |
CY2022Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
4235000 | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
8395000 | ||
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
12664000 | ||
CY2023Q3 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
0 | |
CY2022Q3 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
0 | |
us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
0 | ||
us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
0 | ||
CY2023Q3 | fate |
Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
|
10851000 | |
CY2022Q4 | fate |
Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
|
16858000 | |
CY2023Q3 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
9055000 | |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
17899000 | |
CY2023Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
8634000 | |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
19175000 | |
CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
28540000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
53932000 | |
us-gaap |
Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
|
These leases have terms varying from one to approximately sixteen years, with renewal options of up to ten years | ||
CY2023Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P10Y10M24D | |
CY2023Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0834 | |
CY2023Q3 | us-gaap |
Straight Line Rent Adjustments
StraightLineRentAdjustments
|
3456000 | |
CY2022Q3 | us-gaap |
Straight Line Rent Adjustments
StraightLineRentAdjustments
|
3620000 | |
us-gaap |
Straight Line Rent Adjustments
StraightLineRentAdjustments
|
6817000 | ||
us-gaap |
Straight Line Rent Adjustments
StraightLineRentAdjustments
|
10754000 | ||
CY2023Q3 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
467000 | |
CY2022Q3 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
615000 | |
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
1578000 | ||
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
3614000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
14659000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
15087000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
15540000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
16006000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
15057000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
86579000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
166542000 | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
61588000 | |
CY2023Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
104954000 | |
CY2023Q2 | us-gaap |
Net Rentable Area
NetRentableArea
|
18913 | |
CY2023Q3 | us-gaap |
Sublease Income
SubleaseIncome
|
273000 | |
CY2022Q3 | us-gaap |
Sublease Income
SubleaseIncome
|
0 | |
us-gaap |
Sublease Income
SubleaseIncome
|
456000 | ||
us-gaap |
Sublease Income
SubleaseIncome
|
0 | ||
CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
10104000 | |
CY2022Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
19468000 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
33984000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
59341000 | ||
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
483939000 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
222000 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
1000 | |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
10983000 | |
CY2023Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
1208000 | |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18881000 | |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
477472000 | |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
81000 | |
CY2023Q2 | fate |
Conversion Of Preferred Shares To Common Stock Shares
ConversionOfPreferredSharesToCommonStockShares
|
-33441 | |
CY2023Q2 | fate |
Conversion Of Preferred Shares To Common Stock Value
ConversionOfPreferredSharesToCommonStockValue
|
1000 | |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
12897000 | |
CY2023Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
59000 | |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-52755000 | |
CY2023Q2 | us-gaap |
Shares Issued
SharesIssued
|
2761108 | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
437755000 | |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
10104000 | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
88000 | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-45170000 | |
CY2023Q3 | us-gaap |
Shares Issued
SharesIssued
|
2761108 | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
402777000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
678838000 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3001000 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
1000 | |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
19331000 | |
CY2022Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-2088000 | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-65690000 | |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
633393000 | |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3184000 | |
CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
20542000 | |
CY2022Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-531000 | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-76105000 | |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
580483000 | |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1487000 | |
CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
19468000 | |
CY2022Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
128000 | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-83563000 | |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
518003000 | |
CY2023Q3 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023Q3 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023Q3 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q3 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |